ClassID:

93609

C07C323/47 - CPC Classification

Classification description:

Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms

Recent Application in this class:
#1
20260132105
2026-05-14

CLETHODIM AMINE SALT, PREPARATION METHOD AND USE THEREOF

#2
20240101524
2024-03-28

A METHOD FOR PREPARATION OF 1-(2-((2,4-DIMETHYLPHENYL)THIO)PHENYL) PIPERAZINE AND ITS SALTS

#3
20240018101
2024-01-18

MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY

#4
20230312465
2023-10-05

A PROCESS FOR PREPARATION OF CLETHODIM

#5
20210078944
2021-03-18

Nitrile oxide compound

#6
20200116896
2020-04-16

Composition, film, lens, solid state imaging element, and compounds

#7
20180346392
2018-12-06

THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS

#8
20180134633
2018-05-17

Thioether compounds as nitrification inhibitors

#9
20180057450
2018-03-01

Nitrileoxide compound

#10
20170320898
2017-11-09

Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury

#11
20160376226
2016-12-29

Bisoxime ester photoinitiator and preparation method and use thereof

#12
20160376225
2016-12-29

Nitro-containing bisoxime ester photoinitiator and preparation method and use thereof

#13
20160016964
2016-01-21

Compounds with oxime ester and/or acyl groups

#14
20150338734
2015-11-26

Energy-sensitive resin composition

#15
20150258046
2015-09-17

Doxorubicin adjuvants to reduce toxicity and methods for using the same

#16
20150246939
2015-09-03

Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury

#17
20150141384
2015-05-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DEGENERATIVE DISORDERS

#18
20140200350
2014-07-17

Compounds with oxime ester and/or acyl groups

#19
20120329744
2012-12-27

Doxorubicin adjuvants to reduce toxicity and methods for using the same

#20
20110129778
2011-06-02

Oxime ester compound and photopolymerization initiator containing the same

#21
20110118307
2011-05-19

Compositions and methods for the treatment of infectious diseases

#22
20100249262
2010-09-30

Oxime ester compound and photopolymerization initiator containing the same

#23
20100145068
2010-06-10

Dendritic photoactive compound comprising oxime ester and method for preparing the same

#24
20100075254
2010-03-25

Oxime ester compound and photopolymerization initiator containing the same

#25
20090325893
2009-12-31

Doxorubicin adjuvants to reduce toxicity and methods for using the same

#26
20090298898
2009-12-03

PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES

#27
20090036501
2009-02-05

2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α

#28
20080200525
2008-08-21

Pesticidally active ketone and oxime derivatives

#29
20070275932
2007-11-29

Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders

#30
20060128670
2006-06-15

Pesticidally active ketone and oxime derivatives

#31
20060020041
2006-01-26

Anti tubercular drug: compositions and methods

#32
20050192281
2005-09-01

Nitrone compounds, prodrugs and pharmaceuticals compositons of the same to treat human disorders

#33
20050191567
2005-09-01

Oxime ester photoinitiators

#34
20050059638
2005-03-17

Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders